ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Assessing the Effect of Freezing and Thawing of Samples for Anti-Factor Xa Testing for the Determination of Enoxaparin Activity

S. Louw1,2, R. Gounden1,2, E.S. Mayne2,3, J. Vaughan1,2

1University of the Witwatersrand (WITS), Molecular Medicine and Haematology, Johannesburg, South Africa, 2National Health Laboratory Service (NHLS), Johannesburg, South Africa, 3University of the Witwatersrand (WITS), Immunology, Johannesburg, South Africa

Abstract Number: PB0605

Meeting: ISTH 2020 Congress

Theme: Diagnostics and OMICs » Laboratory Diagnostics

Background: The validity of laboratory results is influenced by pre-analytical variables including the collection technique, transportation and storage. Laboratories often rely on a model of centralisation of specialised testing with onsite processing and subsequent transport to referral centres. Low molecular weight heparin (LMWH) offers improved predictability of anticoagulation effect but in certain clinical scenarios (e.g. extremes of age and renal dysfunction) anti-Factor Xa (aFXa)activity testing is indicated. This test is not always available in smaller laboratories and samples must be centrifuged, separated and frozen on-site. Freezing may influence test results and the impact should be assessed in line with the Clinical and Laboratory Standards Institute (CLSI) guidelines.

Aims: Assess the effect of a freeze-thaw cycle on aFXa results of patients treated with enoxaparin.

Methods: Ethics approval for the study was obtained from the research committee. 25 random samples received within 4 hours of collection in citrate tubes at Johannesburg Academic Hospital, National Health Laboratory Service (NHLS) laboratory for aFXa testing were analysed on a STAGO-R MAX® coagulation analyser with STA-Liquid® aFXa reagent. The samples were then frozen (-80 °C) and transported within 60 days to another NHLS laboratory at Chris Hani Baragwanath Academic Hospital and analysed on Sysmex CS-2500i® analysers with Siemens Innovance® reagent. The aFXa results were compared for agreement.

Results: The aFXa results on the 2 analytical platforms demonstrated acceptable agreement (Figure 1 and Table1):

Figure 1: Bland-Altman difference plot Siemens vs. STAGO anti-Factor Xa (aFXa):


[Figure 1: Bland-Altman difference plot Siemens vs. STAGO anti-Factor Xa (aFXa):]



Table 1: Bias and limits of agreement of Siemens® vs. STAGO® anti Factor Xa (aFXa):

Bias -0.0168
Standard deviation (SD) of Bias 0.02982
95% Limits of Agreement  
From: -0.07525
To: 0.04165

[Table 1: Bias and limits of agreement of Siemens vs. STAGO anti Factor Xa (aFXa):]

Conclusions: The results demonstrated acceptable agreement of aFXa results after a freeze-thaw cycle in stored frozen samples analysed on 2 different analytical platforms.

To cite this abstract in AMA style:

Louw S, Gounden R, Mayne ES, Vaughan J. Assessing the Effect of Freezing and Thawing of Samples for Anti-Factor Xa Testing for the Determination of Enoxaparin Activity [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/assessing-the-effect-of-freezing-and-thawing-of-samples-for-anti-factor-xa-testing-for-the-determination-of-enoxaparin-activity/. Accessed October 1, 2023.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/assessing-the-effect-of-freezing-and-thawing-of-samples-for-anti-factor-xa-testing-for-the-determination-of-enoxaparin-activity/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley